Couldn’t find threads on guggenheim rx exits, pay, and cultures in the forum bedsides the top 5 (HL, PJT, EVERCORE, LAZ, MOE.) Would love to hear if it would be possible to exit into MF or Traditional PE given the recession hit with the increased mandates.
| +267 | Why UBS Is the Worst Place to Start Your IB Career | 40 | 2d |
| +219 | UBS 2nd Year Analyst Q&A (2026) | 41 | 1d |
| +102 | What's your craziest "hardo" story? | 18 | 4h |
| +73 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 11 | 3h |
| +53 | Wolf of Wall Street vs. Reality: Anyone else feel scammed by the movies? | 19 | 18h |
| +50 | Suspended for a Year | 21 | 20h |
| +49 | Elite Boutique interview questions | 17 | 2d |
| +37 | so confused about 28 SA timeline | 30 | 13h |
| +34 | Lincoln International Return Offers | 9 | 1h |
| +33 | Rate my non-target resume | 19 | 7h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump curious too
Bump
Bump
bump
Clearly, they don't exit.
Or too busy to post on this forum?
LoL curious why “no exit”
Guggenheim acquired Millstein less than 2 years ago. Practice is too new for most of the exits to be relevant.
I guess I’m more curious about their potential in one or two years, given the amount of mandates with the increase of distressed companies.
Deleted
Bump
Bump
BUMP
I went through the interview process with them and got a general sense of the language around exits. A handful of people stay on as A2A (more than what I see at comparable firms). Exits unclear. Pay is comparable to firms you listed. I would not go to Gugg RX with the sole intention of exiting (in the same way people think of PJT RX in that manner--particularly because in a way that's how they designed their analyst program). Exits are unclear, they are currently figuring out culture issues and establishing themselves within Gugg (post-Millstein). A few people I talked to said they joined legacy Millstein with the intention of doing RX/banking long-term. From all the conversations I had, I really don't view Gugg RX as the ideal bank to go to for exits.
Deleted
Ut deserunt harum reprehenderit illo ut unde. Ducimus consequatur accusantium est perferendis.
Voluptate iste perspiciatis est totam ea autem sed. Unde nesciunt in autem consequatur autem.
Quis nihil earum alias nobis accusamus ratione repellat. Quibusdam harum et voluptatibus aut reprehenderit dolores. Cupiditate rerum ipsum doloremque dicta velit. Odit culpa voluptatum voluptatem occaecati temporibus maiores. Et magni sequi ipsum sunt.
Sit corrupti est sint et aperiam quo. Vel quidem eius consequatur rerum. Et minus blanditiis ex delectus autem facilis culpa.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...